{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:48:21Z","timestamp":1788997701036,"version":"build-2803163510"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CE"],"DOI":"10.2147\/ce.s81776","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T19:29:32Z","timestamp":1459884572000},"page":"1","source":"Crossref","is-referenced-by-count":22,"title":["Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy"],"prefix":"10.2147","author":[{"given":"Emiliano","family":"Angeloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,4]]},"container-title":["Core Evidence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=29737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:39:33Z","timestamp":1477852773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/azilsartan-medoxomil-in-the-management-of-hypertension-an-evidence-bas-peer-reviewed-article-CE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ce.s81776","relation":{},"ISSN":["1555-175X"],"issn-type":[{"value":"1555-175X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}